Functional analysis of 11q13.5 amplicon identifies Rsf-1 (HBXAP) as a gene involved in paclitaxel resistance in ovarian cancer. - Wikidata - awgldk - TriplyDB

Functional analysis of 11q13.5 amplicon identifies Rsf-1 (HBXAP) as a gene involved in paclitaxel resistance in ovarian cancer.

Functional analysis of 11q13.5 amplicon identifies Rsf-1 (HBXAP) as a gene involved in paclitaxel resistance in ovarian cancer.

http://www.wikidata.org/entity/Q37101421

about

ATP-dependent chromatin remodeling complexes as novel targets for cancer therapy Oncoproteomic analysis reveals co-upregulation of RELA and STAT5 in carboplatin resistant ovarian carcinoma Pathogenesis of ovarian cancer: clues from selected overexpressed genes.Serous tubal intraepithelial carcinoma upregulates markers associated with high-grade serous carcinomas including Rsf-1 (HBXAP), cyclin E and fatty acid synthase Notch3 overexpression is related to the recurrence of ovarian cancer and confers resistance to carboplatin.Identification of a novel role of Septin 10 in paclitaxel-resistance in cancers through a functional genomics screen.Rsf-1, a chromatin remodeling protein, induces DNA damage and promotes genomic instability.RSF1 is a positive regulator of NF-κB-induced gene expression required for ovarian cancer chemoresistance.Genetic variation and reproductive timing: African American women from the Population Architecture using Genomics and Epidemiology (PAGE) Study.Rsf-1 (HBXAP) expression is associated with advanced stage and lymph node metastasis in ovarian clear cell carcinoma.Overexpression of a chromatin remodeling factor, RSF-1/HBXAP, correlates with aggressive oral squamous cell carcinoma.Amplification of the ch19p13.2 NACC1 locus in ovarian high-grade serous carcinoma Rsf-1, a chromatin remodelling protein, interacts with cyclin E1 and promotes tumour development.Galectin 9 and PINCH, novel immunotherapy targets of renal cell carcinoma: a rationale to find potential tumour antigens and the resulting cytotoxic T lymphocytes induced by the derived peptides.Prognostic value of rsf-1/hbxap in human solid tumors: a meta-analysis of cohort studies ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers The Group I Pak inhibitor Frax-1036 sensitizes 11q13-amplified ovarian cancer cells to the cytotoxic effects of Rottlerin.Endocervical-type mucinous borderline tumors are related to endometrioid tumors based on mutation and loss of expression of ARID1A.Integrative network analysis to identify aberrant pathway networks in ovarian cancer miR-320c regulates gemcitabine-resistance in pancreatic cancer via SMARCC1.Next generation deep sequencing identified a novel lncRNA n375709 associated with paclitaxel resistance in nasopharyngeal carcinoma.Effects of p21-activated kinase 1 inhibition on 11q13-amplified ovarian cancer cells.MiR-125a promotes paclitaxel sensitivity in cervical cancer through altering STAT3 expression.RSF1 regulates the proliferation and paclitaxel resistance via modulating NF-κB signaling pathway in nasopharyngeal carcinoma.Oncogenes associated with drug resistance in ovarian cancer.Epigenomic regulation of oncogenesis by chromatin remodeling.miR-30a-5p enhances paclitaxel sensitivity in non-small cell lung cancer through targeting BCL-2 expression.Rsf-1 overexpression serves as a prognostic marker in human hepatocellular carcinoma.Rsf-1 overexpression in human prostate cancer, implication as a prognostic marker.Tectorigenin sensitizes paclitaxel-resistant human ovarian cancer cells through downregulation of the Akt and NFκB pathway.Epigenetic Modifications and Head and Neck Cancer: Implications for Tumor Progression and Resistance to Therapy Remodeling and spacing factor 1 overexpression is associated with poor prognosis in renal cell carcinoma.RSF-1 overexpression determines cancer progression and drug resistance in cervical cancer.Clinical importance of the EMSY gene expression and polymorphisms in ovarian cancer.

P2860

Q26849467-5866A32E-ED5F-4E5E-AE36-B64DF014CAC3 Q28474516-1219C994-84F5-4AFE-8F73-B12CB92043DB Q33651139-9975A898-6098-4CDF-B79C-6D5A1528625F Q33888942-941E6FD0-7447-4F00-8FF2-7DDC76F23E20 Q34086841-9450B15E-4E9D-4F64-AECD-E34D885E1A95 Q34155175-CDEF1FB3-E7A1-42F8-ABCD-40EE80638D58 Q34352173-C0081E7F-56F9-4C26-A7F1-F3E76A32B00D Q34406586-9911E26E-24DD-4E4B-8A4A-941249EA4DD1 Q34592585-FE7B1076-373A-438B-8172-EB1AABA3B0DB Q34643587-2E334930-CE58-49E8-BC01-44FD7E18B59E Q34839580-C3917316-5C2E-4092-B85F-718328CF4CDB Q34899256-CE79E511-CF99-448E-A243-9CC4B23064C8 Q35158463-B5090278-C72D-435F-AA55-ABBAD3D2132E Q35181245-BF2EA524-37AB-42D5-A71B-C8489F300506 Q35479651-A6BC4ACA-111C-4A9A-9873-EBC96CB4C3E1 Q35501591-38FF5F28-926C-4BD6-945C-E70C1A7FD056 Q36079783-685AC8AB-083E-4332-A249-80640135901C Q36411107-3E1F6205-6AA5-4910-8F18-5B3145D9B4DB Q36716928-EB9F7022-48C2-4112-832A-3D9966EE788E Q37040632-B847D0D5-F515-4573-B5A7-B44C3EF6FCF6 Q37258866-97FEFC32-7217-45F9-81FB-B7A3CA85A36B Q37444575-BA01BECC-456C-4EB6-9A1B-2FA3B47372DF Q37499235-395A81F7-0FEF-4A74-82DB-84F5D9950D4B Q37675934-A5636315-9FE3-4CE9-8C88-507EF367F6B4 Q38226577-C7EF2D01-7BD1-44DF-8C04-9A692DE9E5BE Q38709544-61AD7CD0-2F70-45AD-82F8-A18B1CF555DF Q38795063-521FA20C-6761-42AF-B87D-AAA91A1F0C2B Q38998210-E648129E-9C00-4C28-A917-AD71BDF1DA5B Q39019436-CB1FD31B-5C0D-4821-94EA-3903B94699C4 Q39268041-5900B725-011E-4150-85EA-0085FC620FD3 Q39433158-982B865A-E648-4254-AE26-E49E234642F2 Q50331571-38A46F37-0561-46BE-901A-E37B2FBE8554 Q54974939-FD35C8CF-A852-4CED-A9C0-899086EDEDC6 Q55085143-8416CEE8-D85B-491E-B054-15323FE920C6

P2860

Functional analysis of 11q13.5 amplicon identifies Rsf-1 (HBXAP) as a gene involved in paclitaxel resistance in ovarian cancer.

http://www.wikidata.org/entity/Q37101421

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 03 February 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Functional analysis of 11q13.5 ...... resistance in ovarian cancer.

@en

Functional analysis of 11q13.5 amplicon identifies Rsf-1

@nl

type

label

Functional analysis of 11q13.5 ...... resistance in ovarian cancer.

@en

Functional analysis of 11q13.5 amplicon identifies Rsf-1

@nl

prefLabel

Functional analysis of 11q13.5 ...... resistance in ovarian cancer.

@en

Functional analysis of 11q13.5 amplicon identifies Rsf-1

@nl

P1433

Q37101421-DAE98C3B-94C5-4CCE-977E-AD00C4883215

P1476

Q37101421-7B0F5C7D-37FE-4535-8AF1-087F9EC68757

P2093

Q37101421-00B3743F-F716-4762-9951-950C7D446AB7

Q37101421-17F26371-71C8-40C9-B410-074861AF968C

Q37101421-285B92A0-2C79-4237-B9B2-3692DFF7520F

Q37101421-3FDB79DE-D63C-4A32-80C7-4F96BD4ACF98

Q37101421-64BBAF93-56AC-4310-BEEF-07684DE79597

Q37101421-9D3534B3-4117-41A1-A423-5A5026484C39

P2860

Q37101421-036E4517-6F42-4C3D-B041-7FF8D6B1F37F

Q37101421-04B86210-6D52-4506-939E-C65191DDFC03

Q37101421-08DB2F85-3EA3-4A9D-BE6E-FAA36725EA70

Q37101421-0E00DBD2-959A-49CC-8CA7-41BFB27EBC77

Q37101421-0E25B653-65A3-4822-ACAB-6D4D63336749

Q37101421-15E1267F-5465-4D50-9883-D50B129E661F

Q37101421-1B60D9F5-B45B-4B35-8F12-17AA5DFAC246

Q37101421-270CCE5A-AC0E-489F-B9A4-A261D650DB59

Q37101421-2DFC03A5-17EC-476C-BF09-223EB22A1F8D

Q37101421-2F0A4C02-9BE5-4D34-A6A8-C972FA71DD5E

P304

Q37101421-F04B4BCE-28DF-47C0-9CE3-13027BD78450

P31

Q37101421-9B94FDA8-5ABB-4BC1-AE84-1E4DCFFA0F9D

P356

Q37101421-FCAE023B-6324-41EF-9929-A541A9A9357B

P407

Q37101421-29FFF23C-9A6B-483B-98C6-724F76EF2200

P433

Q37101421-2BBDD297-598E-41F3-8EBD-921397921679

P478

Q37101421-EC1C9C78-F07B-4F90-A2FA-87162CAA01F6

P50

Q37101421-EE67F4C8-C0EE-4A57-BF00-A095BF1F5C28

P577

Q37101421-53D7B250-3AC6-44E1-A435-1AD4D6A35E34

P5875

Q37101421-3D113E6B-1E01-4AF5-B948-597778FF3721

P698

Q37101421-BE62E11D-685D-4B41-A3EF-9A20471C5D7F

P921

Q37101421-42DA9436-6DCF-46CE-88CE-4C2BFEC4C394

P932

Q37101421-4FA53D5D-704D-469F-81D5-0D1BB6F3DE76

P356

0008-5472.CAN-08-3602

P1433

Cancer Research

P1476

Functional analysis of 11q13.5 ...... l resistance in ovarian cancer

@en

P2093

Ie-Ming Shih

http://www.w3.org/2001/XMLSchema#string

Jim Jinn-Chyuan Sheu

http://www.w3.org/2001/XMLSchema#string

Jung Hye Choi

http://www.w3.org/2001/XMLSchema#string

Natini Jinawath

http://www.w3.org/2001/XMLSchema#string

Paul Markowski

http://www.w3.org/2001/XMLSchema#string

Tian-Li Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Requirement of RSF and FACT for transcription of chromatin templates in vitro

Digital karyotyping

Oncogenes and Cancer

Hepatitis B virus pX interacts with HBXAP, a PHD finger protein to coactivate transcription

HBXAP, a novel PHD-finger protein, possesses transcription repression activity

Cloning and mapping of SMARCA5 encoding hSNF2H, a novel human homologue of Drosophila ISWI

Functional analysis of the subunits of the chromatin assembly factor RSF

Amplification of a chromatin remodeling gene, Rsf-1/HBXAP, in ovarian carcinoma

A role for the yeast SWI/SNF complex in DNA replication.

Ordered recruitment of transcription and chromatin remodeling factors to a cell cycle- and developmentally regulated promoter.

P304

1407-1415

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-08-3602

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-02-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23974599

http://www.w3.org/2001/XMLSchema#string

P698

19190325

http://www.w3.org/2001/XMLSchema#string

P921

P932

2644345

http://www.w3.org/2001/XMLSchema#string